Metabolon
DURHAM, NC · Biotechnology, Healthcare · 435 employees
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other 'omics' technologies. With 25 years of experience, 15,000+ client projects, 4,000+ scientific publication references, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leadi
Funding history
- Funding Round — $7.5M — Jan 2025
- Funding Round — $60.0M — May 2024
- Funding Round — $25.0M — Jan 2023
- Funding Round — $10.0M — Nov 2022
- Funding Round — $21.8M — Sep 2020
Recent signals
- Jan 14, 2026: Metabolon Appoints Celia Reyes as Vice President of Human Resources
- Feb 27, 2025: Launched Metabolon, Inc. has launched new multiomics biomarker discovery functionality through its Integrated Bioinformatics Platform to enhance multiomics research.
- Jan 14, 2025: Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales
- Jan 10, 2025: Raised $7.5M
- Aug 28, 2024: Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Identify Rheumatoid Arthritis Biomarkers
- May 16, 2024: Raised $60.0M
- Jan 24, 2023: Raised $25.0M
- Nov 10, 2022: Raised $10.0M
See plans & pricing → Track Metabolon’s funding, hiring, and signals — with verified contacts — on Fundz.